Lung Cancer Therapeutics

Lung Cancer Therapeutics Market by Molecules (Biologics, Small Molecules), Disease (NSCLC, SCLC), Cancer Type, Therapy, Distribution - Global Forecast 2024-2030

360iResearch Analyst
SPEAK TO ANALYST? OR FACE-TO-FACE MEETING?
Want to know more about the lung cancer therapeutics market or any specific requirement? Ketan helps you find what you're looking for.
DOWNLOAD A FREE PDF
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.

[181 Pages Report] The Lung Cancer Therapeutics Market size was estimated at USD 25.04 billion in 2023 and expected to reach USD 27.12 billion in 2024, at a CAGR 8.39% to reach USD 44.03 billion by 2030.

Lung Cancer Therapeutics Market
To learn more about this report, request a free PDF copy
Lung Cancer Therapeutics Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Lung Cancer Therapeutics Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Lung Cancer Therapeutics Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Lung Cancer Therapeutics Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Astellas Pharma Inc., AstraZeneca PLC, Boehringer Ingelheim GmbH, Bristol Myers Squibb Company, Celgene Corporation, Eli Lilly and Company, F. Hoffmann-La Roche AG, Genentech, Inc., GlaxoSmithKline PLC, Merck KGaA, Novartis AG, Pfizer Inc., and Sanofi S.A..

Market Segmentation & Coverage

This research report categorizes the Lung Cancer Therapeutics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Molecules
    • Biologics
    • Small Molecules
  • Disease
    • NSCLC
    • SCLC
  • Cancer Type
    • Lung Carcinoid Tumor
    • Non-small Cell Lung Cancer
    • Small Cell Lung Cancer
  • Therapy
    • Chemotherapy
    • Immunotherapy
      • Atezolizumab
      • Durvalumab
      • Nivolumab
      • Pembrolizumab
    • Radiation Therapy
      • External Beam
      • Internal Beam
      • Systemic
    • Targeted Therapy
      • Bevacizumab
      • Dabrafenib/Trametinib
      • Erlotinib Hydrochloride
      • Osimertinib
  • Distribution
    • Hospital Pharmacies
    • Online Phramacies
    • Retail Pharmacies

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Lung Cancer Therapeutics Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Lung Cancer Therapeutics Market?
  3. What are the technology trends and regulatory frameworks in the Lung Cancer Therapeutics Market?
  4. What is the market share of the leading vendors in the Lung Cancer Therapeutics Market?
  5. Which modes and strategic moves are suitable for entering the Lung Cancer Therapeutics Market?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Lung Cancer Therapeutics Market, by Molecules
  7. Lung Cancer Therapeutics Market, by Disease
  8. Lung Cancer Therapeutics Market, by Cancer Type
  9. Lung Cancer Therapeutics Market, by Therapy
  10. Lung Cancer Therapeutics Market, by Distribution
  11. Americas Lung Cancer Therapeutics Market
  12. Asia-Pacific Lung Cancer Therapeutics Market
  13. Europe, Middle East & Africa Lung Cancer Therapeutics Market
  14. Competitive Landscape
  15. Competitive Portfolio
  16. List of Figures [Total: 26]
  17. List of Tables [Total: 738]
  18. List of Companies Mentioned [Total: 14]
Frequently Asked Questions
  1. How big is the Lung Cancer Therapeutics Market?
    Ans. The Global Lung Cancer Therapeutics Market size was estimated at USD 25.04 billion in 2023 and expected to reach USD 27.12 billion in 2024.
  2. What is the Lung Cancer Therapeutics Market growth?
    Ans. The Global Lung Cancer Therapeutics Market to grow USD 44.03 billion by 2030, at a CAGR of 8.39%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.